Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma

Figure 7

Validation of RAB3A, TYROBP, SYP, CAMK2A, VSIG4, and GABRA1 (a–f) gene expression using real‐time quantitative polymerase chain reaction in glioma samples (normal: 6; glioma: 12). ROC curves for RAB3A, TYROBP, SYP, CAMK2A, VSIG4, and GABRA1 (g–l) in our glioma samples (normal: 6; glioma: 12). ROC: receiver operating characteristic.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)